Warning: Undefined variable $zfal in C:\Inetpub\vhosts\kidney.de\httpdocs\mlpefetch.php on line 525
Deprecated: str_replace(): Passing null to parameter #3 ($subject) of type array|string is deprecated in C:\Inetpub\vhosts\kidney.de\httpdocs\mlpefetch.php on line 525
Warning: Undefined variable $sterm in C:\Inetpub\vhosts\kidney.de\httpdocs\mlpefetch.php on line 530
free
Warning: Undefined variable $sterm in C:\Inetpub\vhosts\kidney.de\httpdocs\mlpefetch.php on line 531
free free
English Wikipedia
Nephropedia Template TP (
Twit Text
DeepDyve Pubget Overpricing |
lüll Treatment of lymphomatous and leukemic meningitis with liposomal encapsulated cytarabine Kripp M; Hofheinz RDInt J Nanomedicine 2008[]; 3 (4): 397-401Liposomal encapsulated cytarabine (DepoCyte, Mundipharma GmbH, Limburg/Lahn, Germany) is a slow-release formulation of conventional cytarabine. It is licensed for intrathecal use in patients with lymphomatous and leukemic meningitis. DepoCyte obtained superior response rates, improved patient quality of life and improved the time to neurological progression in a randomized albeit small clinical trial. In this review we briefly summarize the clinical data and discuss them in light of clinical problems and possible treatment scenarios.|*Clinical Trials as Topic[MESH]|Antimetabolites, Antineoplastic/administration & dosage[MESH]|Capsules[MESH]|Cytarabine/*administration & dosage[MESH]|Humans[MESH]|Injections, Spinal[MESH]|Leukemia/*complications/*drug therapy[MESH]|Liposomes[MESH]|Lymphoma/complications/*drug therapy[MESH]|Meningitis/*drug therapy/*etiology[MESH]|Treatment Outcome[MESH] |